Preprint Article Version 1 Preserved in Portico This version is not peer-reviewed

Generalized Rash in Severe Hospitalized COVID Patients: Correlation between Histological Examination, Drug Intake, Blood Interleukins Profileand Long-Term Follow-Up

Version 1 : Received: 24 September 2023 / Approved: 25 September 2023 / Online: 25 September 2023 (09:37:37 CEST)

How to cite: Fernández-Guarino, M.; Stewart, V.; Fernández-Nieto, D.; Moreno Garcia del Real, C.; Gonzalez de Olano, D.; Blanco, C.; Solano-Solares, E.; De la Hoz Caballer, B.; Martínez-Botas, J.; Garcia-Bermejo, M.L.; Andrés-Martín, A. Generalized Rash in Severe Hospitalized COVID Patients: Correlation between Histological Examination, Drug Intake, Blood Interleukins Profileand Long-Term Follow-Up. Preprints 2023, 2023091665. https://doi.org/10.20944/preprints202309.1665.v1 Fernández-Guarino, M.; Stewart, V.; Fernández-Nieto, D.; Moreno Garcia del Real, C.; Gonzalez de Olano, D.; Blanco, C.; Solano-Solares, E.; De la Hoz Caballer, B.; Martínez-Botas, J.; Garcia-Bermejo, M.L.; Andrés-Martín, A. Generalized Rash in Severe Hospitalized COVID Patients: Correlation between Histological Examination, Drug Intake, Blood Interleukins Profileand Long-Term Follow-Up. Preprints 2023, 2023091665. https://doi.org/10.20944/preprints202309.1665.v1

Abstract

Background: There have been few reports of cutaneous skin lesions in severe COVID-19 hospitalized patients which exhibit different behavior compared to outpatients. Furthermore, a notable lack of rigorous studies exits. In this study we included patients with generalized rash during the first wave of the pandemic for characterization.Methods: Hospitalized patients with severe confirmed pulmonary COVID-19 infection and a generalized cutaneous rash during the first wave in March-May 2020 were included. The study received approval from the ethics committee. Clinical presentation, histo-logical examination, blood test, and complete blood interleukin profile were assessed. Special immunohistochemical investigations were conducted. Long term follow-up of the patient was performed throuhg a phone call 24 months later. Results: A total 28 patients were studied and classified by histological examination into three groups: G1: perivascular dermatitis (18/28, 64%); G2: Drug reaction (7/28, 25%); and G3: Generalized exanthema and chilblain (3/28, 11%). The virus was not detected in the skin, by PCR and by immunohistochemical analysis, and the interleukin expression in the skin were undetectable results. Vascular cell adhesion molecule 1 (VCAM1), E-selectine, and IT Galpha 5 were unspecific. G1 exhibited the least inflammation, G2 the most in-flammatory, and G3 had previous inflammation. Discussion: Our data suggest that generalized exanthemas during severe SARS-Cov-2 infection exhibit unspecific finding and are similar to other rashes caused by inflammation. Drug reaction should be considered, as they accounted for 25% of the rashes. Further studies including higher number of patients are necessary.

Keywords

skin; COVID infection; cytokines; SARS-CoV-2

Subject

Medicine and Pharmacology, Dermatology

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.

Leave a public comment
Send a private comment to the author(s)
* All users must log in before leaving a comment
Views 0
Downloads 0
Comments 0
Metrics 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.